Jyothy Labs Stock: Buy Signal for Long-Term Investors?

Jyothy Labs, known for brands like Ujala and Henko, has experienced a substantial stock correction over the past year, with shares falling approximately 30% to ₹259.50. This underperformance is noted against FMCG peers, attributed to slowed earnings growth and compressed valuations.

However, recent performance indicates stabilization. Q3FY26 saw positive volume growth, with notable recovery in personal care and household insecticides, alongside continued strength in fabric care. This is supported by improving rural demand and traction in modern trade and e-commerce channels.

The company boasts a net-debt-free balance sheet and healthy volume growth, despite weak pricing. Fabric care remains its largest segment, contributing 44% of FY25 revenue, followed by dish wash (34%). Recent financial performance for 9MFY26 showed modest overall revenue growth of 2.2% and 4.5% volume growth, with gross margins declining to 47.5%.

Despite margin pressures, catalysts for growth are emerging. Household insecticides are showing recovery, with a strategic shift towards higher-margin products. New product launches in personal care and fabric care have also shown promise, indicating potential for a gradual re-rating over the next three to five years.

The stock is currently trading at an attractive valuation, about 24 times one-year forward earnings, representing a 20% discount to its five-year average. This favorable risk-reward profile suggests a potential buying opportunity for long-term investors with a three-to-five-year horizon.